Our Executives
Paul Lirette, President
 |
Paul Lirette assumed his role as President of GlaxoSmithKline Inc. (GSK) in June 2012 and is responsible for all pharmaceutical operations in Canada. A native of Montreal, Mr. Lirette is an industry leader with 25 years of global pharmaceutical experience and has held international leadership roles with GSK in both Europe and Australia. |
Cynthia Ban, Interim Deputy Compliance Officer
Cynthia Ban has assumed the role of Deputy Compliance Officer for GSK Canada for 2013. In this role Cynthia is part of the GSK Canada Pharma Leadership Team and has responsibility for providing guidance and oversight to GSK Canada Pharma in GSK's codes, policies and standards thereby ensuring GSK's commitment to high standards of integrity and legal compliance. |
Dr. Glenn Crater, Country Medical Director, GlaxoSmithKline Inc.
 |
As a member of the Pharma Leadership Team of GlaxoSmithKline Inc., Dr. Glenn Crater leads GSK's Canadian Medical Affairs team. |
Tom Day, Finance Director
 |
Tom Day was appointed Finance Director in March, 2011. In his current role, Tom leads the Canadian finance business and is a member of the Canadian Executive Team. |
Dr. Rav Kumar, Vice-President, Regulatory & Development Operations
 |
Dr. Rav Kumar leads GlaxoSmithKline's Canadian Research & Development organization of 150 scientists and staff involved in clinical research, regulatory affairs and external R&D alliances. |
Tracy Lapointe, Vice-President, Human Resources
 |
Tracy Lapointe was appointed Vice-President, Human Resources in January 2011 and is responsible for leading the company's Canadian Human Resources function, which includes support for GSK's various business units across the country - Pharma, Consumer Healthcare, Biologicals, ViiV Healthcare, GMS, and R&D. |
Patrick McGrade, Vice-President, Corporate and Legal Affairs and Corporate Secretary
 |
As a member of the Canadian Executive Team of GlaxoSmithKline Inc., Patrick McGrade leads GSK's Corporate and Legal Affairs Division. |
Grant Perry, Vice-President, Public Affairs and Reimbursement
 |
Grant Perry was appointed Vice-President, Public Affairs and Reimbursement in March, 2010. Grant leads the company's government relations, public policy development, patient advocacy and market access initiatives. |
Sarah Robertson, Director, Communications and Linguistics Services
As a member of the Pharma Leadership Team, Sarah Robertson leads the Communications and Linguistic Services Division. Sarah is responsible for the development and management of GSK in Canada's internal and external communication strategies and community partnerships |
Cindy Roll, Vice-President Marketing
 |
Cindy Roll joined GlaxoSmithKline in 2006 with significant experience and demonstrated leadership abilities within the pharmaceutical industry. She was appointed Vice President of Marketing in November 2012 and is responsible for leading the company's Canadian marketing activities. |
Chris Watters, Vice-President, Sales
 |
Chris Watters was appointed to Vice-President, Sales in January 2011 and is responsible for leading the company's Canadian Sales activities. |
Sue West, Vice-President Global Manufacturing and Supply
 |
Sue West was appointed Vice-President, Global Manufacturing and Supply (GMS) in July 2010 where she leads the company's Canadian Pharma Manufacturing function which includes production, logistics, engineering, technical development, quality control and quality assurance. |